메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ObjectiveThe purpose of this study was to evaluate the effectiveness of scheduled ramosetron injections for controllingpostoperative nausea and vomiting (PONV) after single-port access total laparoscopic hysterectomy (SPA-TLH). MethodsNinety patients who underwent SPA-TLH at the Korean National Health Insurance Service Ilsan Hospital between June2013 and July 2014 were enrolled in this prospective, randomized, double-blinded, placebo-controlled study. Thepatients were divided into 2 groups as follows: the ramosetron group (0.3 mg intravenously [IV]; n=45) and the placebogroup (normal saline IV; n=45). Both groups received their respective injections 12 and 24 hours post surgery. Theincidence and severity of PONV (numerical rating scale, 0–10), and the use of rescue antiemetics post surgery wereevaluated. ResultsDemographic and perioperative statistically significant differences were not observed between the 2 groups. Theincidence of PONV in the ramosetron and placebo groups was 46.7% and 51.1%, respectively (P=0.51). We foundsignificant differences in the severity of PONV between the 24- to 48-hour postoperative periods in both groups(ramosetron group, P=0.04 and placebo group, P=0.03). The use of rescue antiemetics was significantly lower in theramosetron group than in the placebo group (P=0.02). ConclusionAfter general anesthesia, scheduled injections of ramosetron 12 and 24 hours after SPA-TLH reduced the severity ofPONV and the use of rescue antiemetics. Administration of ramosetron can be considered not only immediately afterSPA-TLH but also during the first 24-hour recovery period. Trial RegistrationClinicalTrials.gov Identifier: NCT 02011659

목차

등록된 정보가 없습니다.

참고문헌 (24)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0